These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 18997619

  • 1. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
    ten Heuvel SE, Hoekstra HJ, Bastiaannet E, Suurmeijer AJ.
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
    [Abstract] [Full Text] [Related]

  • 2. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
    Guillou L, Benhattar J, Bonichon F, Gallagher G, Terrier P, Stauffer E, Somerhausen Nde S, Michels JJ, Jundt G, Vince DR, Taylor S, Genevay M, Collin F, Trassard M, Coindre JM.
    J Clin Oncol; 2004 Oct 15; 22(20):4040-50. PubMed ID: 15364967
    [Abstract] [Full Text] [Related]

  • 3. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
    Takenaka S, Ueda T, Naka N, Araki N, Hashimoto N, Myoui A, Ozaki T, Nakayama T, Toguchida J, Tanaka K, Iwamoto Y, Matsumine A, Uchida A, Ieguchi M, Kaya M, Wada T, Baba I, Kudawara I, Aoki Y, Yoshikawa H.
    Oncol Rep; 2008 Feb 15; 19(2):467-76. PubMed ID: 18202796
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
    Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M.
    N Engl J Med; 1998 Jan 15; 338(3):153-60. PubMed ID: 9428816
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.
    Stegmaier S, Leuschner I, Poremba C, Ladenstein R, Kazanowska B, Ljungman G, Scheer M, Blank B, Bielack S, Klingebiel T, Koscielniak E.
    Pediatr Blood Cancer; 2017 Jan 15; 64(1):89-95. PubMed ID: 27621063
    [Abstract] [Full Text] [Related]

  • 8. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].
    Sun Y, Sun BC, Zhao XL, Wang J, Chen J, Li XQ, Feng YM, Fang ZW, Hao XS.
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul 15; 36(7):480-4. PubMed ID: 17845763
    [Abstract] [Full Text] [Related]

  • 9. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
    Antonescu CR, Kawai A, Leung DH, Lonardo F, Woodruff JM, Healey JH, Ladanyi M.
    Diagn Mol Pathol; 2000 Mar 15; 9(1):1-8. PubMed ID: 10718206
    [Abstract] [Full Text] [Related]

  • 10. Synovial sarcoma. A Scandinavian Sarcoma Group project.
    Skytting B.
    Acta Orthop Scand Suppl; 2000 Apr 15; 291():1-28. PubMed ID: 10862210
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma.
    Sun Y, Sun B, Wang J, Cai W, Zhao X, Zhang S, Hao X.
    Cancer Sci; 2009 Jun 15; 100(6):1018-25. PubMed ID: 19385976
    [Abstract] [Full Text] [Related]

  • 13. Detection of SYT-SSX fusion transcripts in paraffin-embedded tissues of synovial sarcoma by reverse transcription-polymerase chain reaction.
    Wei Y, Wang J, Zhu X, Shi D, Hisaoka M, Hashimoto H.
    Chin Med J (Engl); 2002 Jul 15; 115(7):1043-7. PubMed ID: 12150740
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Detection and analysis of SYT-SSX fusion gene in synovial sarcoma].
    Xu Z, Yang T, Wu B, Zhong H, Yang Z, Zhou B, Zhang C, Zheng J.
    Zhonghua Bing Li Xue Za Zhi; 2001 Dec 15; 30(6):431-3. PubMed ID: 11866985
    [Abstract] [Full Text] [Related]

  • 16. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.
    Coindre JM, Pelmus M, Hostein I, Lussan C, Bui BN, Guillou L.
    Cancer; 2003 Dec 15; 98(12):2700-7. PubMed ID: 14669292
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synovial sarcoma: the importance of size and location for survival.
    Deshmukh R, Mankin HJ, Singer S.
    Clin Orthop Relat Res; 2004 Feb 15; (419):155-61. PubMed ID: 15021147
    [Abstract] [Full Text] [Related]

  • 20. Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.
    Tvrdík D, Povýsil C, Svatosová J, Dundr P.
    Med Sci Monit; 2005 Mar 15; 11(3):MT1-7. PubMed ID: 15735574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.